4/2016
7
New-inhibitors-of-DNA-methyltransferase-1-based-on-cytosine-scaffold,85,28885,0
abstract:</div><div>SHORT COMMUNICATIONS
New inhibitors of DNA methyltransferase 1 based on cytosine scaffold
h3>Agnieszka Fedoruk-Wyszomirska, Wojciech T. Markiewicz, Jan Barciszewski</h3><div>BioTechnologia vol. 97(4) C pp. 323-325 C 2016
6.64550">https://doi.org/10.5114/bta.2016.64550
a>View full text</a
28885
Fedoruk-Wyszomirska A, Markiewicz W, Barciszewski J. New inhibitors of DNA methyltransferase 1 based on cytosine scaffold. BioTechnologia. 2017;97(4):323-325. doi:10.5114/bta.2016.64550
Fedoruk-Wyszomirska, A., Markiewicz, W., &amp; Barciszewski, J. (2017). New inhibitors of DNA methyltransferase 1 based on cytosine scaffold. BioTechnologia, 97(4), 323-325. https://doi.org/10.5114/bta.2016.64550
Fedoruk-Wyszomirska, Agnieszka, Wojciech T. Markiewicz, and Jan Barciszewski. 2017. "New inhibitors of DNA methyltransferase 1 based on cytosine scaffold". BioTechnologia 97 (4): 323-325. doi:10.5114/bta.2016.64550
Fedoruk-Wyszomirska, A., Markiewicz, W., and Barciszewski, J. (2017). New inhibitors of DNA methyltransferase 1 based on cytosine scaffold. BioTechnologia, 97(4), pp.323-325. https://doi.org/10.5114/bta.2016.64550
Fedoruk-Wyszomirska, Agnieszka et al. "New inhibitors of DNA methyltransferase 1 based on cytosine scaffold." BioTechnologia, vol. 97, no. 4, 2017, pp. 323-325. doi:10.5114/bta.2016.64550
null
<b>United States Patent</b><br><br>Patent number: US9040490 B2<br><br>Application number: US 13/576709<br><br>Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor,<br><br>a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with<br><br>deviations from normal DNA methylation<br><br>Inventors: J. Barciszewski, W.T. Markiewicz, E. Adamska, B. Plitta, M. Giel-Pietraszuk, E. Wyszko, M. Markiewicz,<br><br>A. Fedoruk-Wyszomirska, T. Kulinski, M. Chmielewski<br><br>Assignee: Institute of Bioorganic Chemistry, PAS, Poznań<br><br>Date of Patent: 26. 05. 2015<br><br><br><br><br><br><b>European Patent Application</b><br><br>PCT number: PCT/PL2011/000032<br><br>Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor,<br><br>a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with<br><br>deviations from normal DNA methylation<br><br>Inventors: J. Barciszewski, W.T. Markiewicz, E. Adamska, B. Plitta, M. Giel-Pietraszuk, E. Wyszko, M. Markiewicz,<br><br>A. Fedoruk-Wyszomirska, T. Kulinski, M. Chmielewski<br><br>Assignee: Institute of Bioorganic Chemistry, PAS, Poznań<br><br>Application Date: 17. 03. 2011<br><br><br><br><br><br><b>Polish Patent Application</b><br><br>Polish Application number: P 390 769<br><br>Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor,<br><br>a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with<br><br>deviations from normal DNA methylation<br><br>Inventors: J. Barciszewski, W.T. Markiewicz, E. Adamska, B. Plitta, M. Giel-Pietraszuk, E. Wyszko, M. Markiewicz,<br><br>A. Fedoruk-Wyszomirska, T. Kulinski, M. Chmielewski<br><br>Assignee: Institute of Bioorganic Chemistry, PAS, Poznań<br><br>Application Data: 19. 03. 2010<br><br>Published also as: EP2556081A2, US20120322755, WO2011115513A2, WO2011115513A3, WO2011115513A9<br><br><br><br><b>Abstract</b><br><br>In this study, a cytosine analog and its preparation method and a DNA methyltransferase 1 inhibitor and a method for DNA methylation inhibition are provided for the treatment of diseases associated with deviations from normal<br><br>DNA methylation. The analog of cytosine comprises of 1, N4, 5, and 6-substituted derivatives of cytosine or 5,6-dihydrocytosine; the analog can be described with a chemical formula where R1 is H, R3, R4, 2-deoxyribosyl, R4<br><br>is alkyl or aryl, X is N or C – if X in formula I is N, then R5 is no substituent and if X in formula I and/or II is C or if X in formula II is N, then R5 and R6 are independently alkyl, aryl, hydroxyalkyl, aminoalkyl, hydroxyl, carboxyl,<br><br>amino group, alkoxyl, aryloxyl, aminoalkyl, aminoaryl, thio group, sulfonyl, sulfinyl, or halogen.</div
